litlas
ログインアカウント作成

Stephen H. Caldwell

1989–2025 年に発表

106
論文数
27,085
被引用数
78
h 指数
105
i10 指数

被引用数

Stephen H. Caldwell の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 3 件1997 年: 被引用 2 件1998 年: 被引用 10 件1999 年: 被引用 17 件2000 年: 被引用 37 件2001 年: 被引用 44 件2002 年: 被引用 100 件2003 年: 被引用 76 件2004 年: 被引用 153 件2005 年: 被引用 142 件2006 年: 被引用 123 件2007 年: 被引用 155 件2008 年: 被引用 162 件2009 年: 被引用 201 件2010 年: 被引用 242 件2011 年: 被引用 205 件2012 年: 被引用 174 件2013 年: 被引用 249 件2014 年: 被引用 212 件2015 年: 被引用 207 件2016 年: 被引用 228 件2017 年: 被引用 222 件2018 年: 被引用 253 件2019 年: 被引用 809 件2020 年: 被引用 1,074 件2021 年: 被引用 1,089 件2022 年: 被引用 792 件2023 年: 被引用 733 件2024 年: 被引用 1,253 件2025 年: 被引用 641 件2026 年: 被引用 35 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,848 件、この内訳の 24.2%中国: 引用元論文 1,209 件、この内訳の 10.3%イタリア: 引用元論文 881 件、この内訳の 7.5%イギリス: 引用元論文 723 件、この内訳の 6.1%ドイツ: 引用元論文 481 件、この内訳の 4.1%フランス: 引用元論文 436 件、この内訳の 3.7%日本: 引用元論文 434 件、この内訳の 3.7%スペイン: 引用元論文 403 件、この内訳の 3.4%カナダ: 引用元論文 315 件、この内訳の 2.7%韓国: 引用元論文 292 件、この内訳の 2.5%オーストラリア: 引用元論文 266 件、この内訳の 2.3%インド: 引用元論文 246 件、この内訳の 2.1%
0%24.2%その他 27.4%

機関

分野

  • Medicine87.4%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Immunology and Microbiology0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Nursing0.5%
  • Neuroscience0.3%
  • その他1.4%

トピック

  • Liver Disease Diagnosis and Treatment24.4%
  • Liver Disease and Transplantation9.4%
  • Diet, Metabolism, and Disease5.6%
  • Liver Diseases and Immunity3.3%
  • Hepatocellular Carcinoma Treatment and Prognosis3.2%
  • Alcohol Consumption and Health Effects3%
  • その他51.1%

共著者

全論文

検索で開く
  1. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

    著者: Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, Manal F. Abdelmalek, Stephen H. Caldwell, Diana Barb, David E. Kleiner, Rohit Loomba - Hepatology 2023 被引用: 2,253

  2. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

    著者: Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Natalie Bzowej, Raj Vuppalanchi, Ziad Younes, Anita Kohli, Shiv Kumar Sarin, Stephen H. Caldwell, Naim Alkhouri, Mitchell L. Shiffman, Marianne Camargo, Georgia Li, Kathryn Kersey, Catherine Jia, Yanni Zhu, C. Stephen Djedjos, G. Mani Subramanian, Robert P. Myers, Nadege Gunn, Aasim Sheikh, Quentin M. Anstee, Manuel Romero‐Gómez, Michael Trauner, Zachary Goodman, Eric Lawitz, Zobair M. Younossi, Adrián Gadano, Marcelo Martins, Peter Angus, John Bate, Mark Danta, Jacob George, Alexander Hodge, Nickolas Kontorinis, S.A. Roberts, Santosh Sanagapalli, Richard Skoien, Alexander Thompson, Amany Zekry, Rudolf Stauber, Michael Trauner, Christophe Moreno, Hendrik Reynaert, Len Verbeke, Mário Reis Álvares‐da‐Silva, Edison Roberto Parise, Cláudia P. Oliveira, Roberta Chaves Araújo, Ana de Lourdes Candolo Martinelli, Meredith A. Borman, Natasha Chandok, Magdy Elkhashab, Hughie F. Fraser, Kelly Kaita, Mang Ma, Paul Marotta, Alnoor Ramji, Edward Tam, Eric M. Yoshida, Mark G. Swain, Giada Sebastiani, Denis Petrunia, Armand Abergel, Rodolphe Anty, Marc Bourlière, Jérôme Boursier, Christophe Bureau, Laurent Castéra, François Habersetzer, Christophe Hézode, V. de Lédinghen, Vincent Leroy, V. Loustaud‐Ratti, Philippe Mathurin, Stanislas Pol, Fabien Zoulim, Holger Hinrichsen, Patrick Ingiliz, Frank Lammert, Michael Manns, Jörn M. Schattenberg, Ingolf Schiefke, Christian Trautwein, Stefan Zeuzem, Aric J. Hui, K Li, Vincent Wai‐Sun Wong, Subrat Kumar Acharya, Abhijit Chowdhury, Ajay Duseja, Dharmesh Kapoor, Shrikant Mukewar, Shiv Kumar Sarin, Samir Shah, S. Shalimar, Ajit Sood, BV Tantry, Ziv Ben‐Ari, Helena Katchman ほか 540 名 - Journal of Hepatology 2020 被引用: 466

  3. Liver biopsy†

    著者: Don C. Rockey, Stephen H. Caldwell, Zachary Goodman, Rendon C. Nelson, Alastair D. Smith - Hepatology 2008 被引用: 1,950

  4. Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

    著者: Rohit Loomba, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal Raj Bhandari, Nadege Gunn, Stephen H. Caldwell, Zachary Goodman, Ilan Wapinski, Murray B. Resnick, Andrew H. Beck, Dora Ding, Catherine Jia, Jen‐Chieh Chuang, Ryan S. Huss, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Keyur Patel, Brian B. Borg, Reem Ghalib, Heidi Kabler, John Poulos, Ziad Younes, Magdy Elkhashab, Tarek Hassanein, Rajalakshmi Iyer, Peter Ruane, Mitchell L. Shiffman, Simone I. Strasser, Vincent Wai‐Sun Wong, Naim Alkhouri, for the ATLAS Investigators - Hepatology 2020 被引用: 278

  5. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

    著者: Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric Lawitz, Don C. Rockey, Raul Aguilar Schall, Catherine Jia, B. Mccolgan, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Zobair M. Younossi, Vlad Ratziu, Andrew J. Muir, Nezam H. Afdhal, Zachary Goodman, Jaime Bosch, Arun J. Sanyal - Gastroenterology 2018 被引用: 372

  6. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

    著者: Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Stephen H. Caldwell, Mitchell L. Shiffman, Raul Aguilar Schall, Catherine Jia, B. Mccolgan, C. Stephen Djedjos, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Zobair M. Younossi, Andrew J. Muir, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman - Hepatology 2019 被引用: 389

  7. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

    著者: Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, Kosh Agarwal, Andrew J. Muir, Simon Rushbrook, Xiaomin Lu, Jun Xu, Jen‐Chieh Chuang, Andrew N. Billin, Georgia Li, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley - Hepatology 2019 被引用: 259

  8. Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases

    著者: Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo - Alimentary Pharmacology & Therapeutics 2018 被引用: 330

  9. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

    著者: Rohit Loomba, Eric Lawitz, Parvez Mantry, Saumya Jayakumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, C. Stephen Djedjos, Ling Han, Robert P. Myers, G. Mani Subramanian, John G. McHutchison, Zachary Goodman, Nezam H. Afdhal, Michael Charlton, for the GS‐US‐384‐1497 Investigators - Hepatology 2017 被引用: 553

  10. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    著者: Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Zachary Goodman, Naga P. Chalasani, Kris V. Kowdley, Jacob George, Keith D. Lindor - Hepatology 2017 被引用: 427

  11. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

    著者: Jörn M. Schattenberg, Albert Parés, Kris V. Kowdley, Michael A. Heneghan, Stephen H. Caldwell, Daniel S. Pratt, Alan Bonder, Gideon M. Hirschfield, Cynthia Levy, John M. Vierling, David Jones, Anne Tailleux, Bart Staels, S. Megnien, Rémy Hanf, David Magrez, P Birman, Velimir A. Luketic - Journal of Hepatology 2021 被引用: 178

  12. Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease

    著者: Andrew J. Muir, Cynthia Levy, Harry L.A. Janssen, Aldo J. Montaño‐Loza, Mitchell L. Shiffman, Stephen H. Caldwell, Velimir A. Luketic, Dora Ding, Catherine Jia, B. Mccolgan, John G. McHutchison, G. Mani Subramanian, Robert P. Myers, Michael P. Manns, Roger W. Chapman, Nezam H. Afdhal, Zachary Goodman, Bertus Eksteen, Christopher L. Bowlus, for the GS‐US‐321‐0102 Investigators - Hepatology 2018 被引用: 193

  13. Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

    著者: György Baffy, Elizabeth M. Brunt, Stephen H. Caldwell - Journal of Hepatology 2012 被引用: 848

  14. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    著者: Amedeo Lonardo, Fernando Bril, Stephen H. Caldwell, Mohammed Eslam, Jian‐Gao Fan, Robert G. Gish, Henning Grønbæk, Sanal Madhusudana Girija, Norbert Stefan, Ayako Suzuki, Giovanni Targher, Herbert Tilg, Ming‐Lung Yu, Ming‐Hua Zheng, Jacob George - Journal of Hepatology 2024 被引用: 33

  15. AGA Clinical Practice Update: Coagulation in Cirrhosis

    著者: Jacqueline G. O’Leary, Charles S. Greenberg, Heather Patton, Stephen H. Caldwell - Gastroenterology 2019 被引用: 438

  16. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    著者: Zobair M. Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander‐Tetri, Lawrence Serfaty, Francesco Negro, Stephen H. Caldwell, Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel E. Lavine, Philippe Mathurin, Michael Charlton, Naga Chalasani, Quentin M. Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith D. Lindor - Hepatology 2017 被引用: 361

  17. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    著者: Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, Sanjaya K. Satapathy, Marwan Ghabril, Mitchell L. Shiffman, Ziad Younes, Paul J. Thuluvath, Annalisa Berzigotti, Agustı́n Albillos, James M. Robinson, David Hagerty, Jean L. Chan, Arun J. Sanyal, Manal F. Abdelmalek, K.R. Bhamidimarri, Brian B. Borg, Stephen H. Caldwell, Jonathan M. Fenkel, B. Freilich, Michael Fuchs, Marwan Ghabril, R. Ghalib, Stevan A. Gonzalez, Sonya G. Gordon, Bilal Hameed, Stephen A. Harrison, Zeid Kayali, Nyingi Kemmer, Kevin Korenblat, Ming‐Zong Lai, Charles Landis, E.J. Lawitz, William M. Lee, Steven D. Lidofsky, Edward Mena, Mazen Noureddin, Angelo H. Paredes, Nikolaos Pyrsopoulos, K. Rajender Reddy, M. Rinella, Don C. Rockey, Manuel Rodríguez, Michele B. Ryan, Souvik Sarkar, Sanjaya K. Satapathy, Andrew Scanga, Mitchell L. Shiffman, Mohammad Shadab Siddiqui, Douglas A. Simonetto, Wing‐Kin Syn, Paul J. Thuluvath, Ramesh Vemulapalli, John M. Vierling, Ziad Younes, Agustı́n Albillos, Juan Arenas Ruiz-Tapiador, Salvador Augustín, José Luís Calleja, J. Crespo Garcia, L. García Buey, Juan Carlos García‐Pagán, Càndid Villanueva, C. Bureau, N. Carbonell, Valériane Leroy, Pierre‐Emmanuel Rautou, HS Heinzow, Ingolf Schiefke, Alexander Zipprich, Annalisa Berzigotti, Beat Muellhaupt - Journal of Hepatology 2019 被引用: 156

  18. Haemostatic alterations and management of haemostasis in patients with cirrhosis

    著者: Ton Lisman, Stephen H. Caldwell, Nicolas M. Intagliata - Journal of Hepatology 2022 被引用: 117

  19. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis

    著者: Nicolas M. Intagliata, Stephen H. Caldwell, Armando Tripodi - Gastroenterology 2019 被引用: 360

  20. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial

    著者: Curtis K. Argo, James T. Patrie, Carolin Lackner, Thomas D. Henry, Eduard E. de Lange, Arthur Weltman, Neeral L. Shah, Abdullah Al‐Osaimi, Patcharin Pramoonjago, Saumya Jayakumar, Lukas Binder, Winsor D. Simmons-Egolf, Sandra G. Burks, Yongde Bao, Ann Gill Taylor, Jessica Rodriguez, Stephen H. Caldwell - Journal of Hepatology 2014 被引用: 224

  21. Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference

    著者: Brent A. Neuschwander‐Tetri, Stephen H. Caldwell - Hepatology 2003 被引用: 2,149

  22. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib

    著者: Saumya Jayakumar, Michael S. Middleton, Eric Lawitz, Parvez Mantry, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, Reem Ghalib, Magdy Elkhashab, Manal F. Abdelmalek, Kris V. Kowdley, C. Stephen Djedjos, Ren Xu, Ling Han, G. Mani Subramanian, Robert P. Myers, Zachary Goodman, Nezam H. Afdhal, Michael Charlton, Claude B. Sirlin, Rohit Loomba - Journal of Hepatology 2018 被引用: 206

  23. Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis

    著者: Raj Vuppalanchi, Stephen H. Caldwell, Nikolaos Pyrsopoulos, Andrew S. deLemos, Simona Rossi, Cynthia Levy, David S. Goldberg, Edward Mena, Aasim Sheikh, Ravi Ravinuthala, Farheen Shaikh, James D. Bainbridge, Deven V. Parmar, Naga Chalasani - Journal of Hepatology 2021 被引用: 73

  24. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

    著者: Douglas A. Simonetto, Ashwani K. Singal, Guadalupe García–Tsao, Stephen H. Caldwell, Joseph Ahn, Patrick S. Kamath - The American Journal of Gastroenterology 2020 被引用: 219